Evidence map›Paper›PMID 25550400›Full record

ArticleCirculation. Cardiovascular imaging2015

Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm.

Reza Golestani, Mahmoud Razavian, Lei Nie, Jiasheng Zhang, Jae-Joon Jung, Yunpeng Ye, Michelle de Roo, Koen Hilgerink, Chi Liu, Simon P Robinson and 1 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Circulation. Cardiovascular imaging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Playing slot to hitting the jackpot in molecular imaging: On probability of uncovering subcellular pathogenesis vs achieving clinical applicability.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  17. Multi-modality molecular imaging of aortic aneurysms.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  18. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Article
  19. Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Article
  20. Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Reza GolestaniFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Mahmoud RazavianFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Lei NieFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Jiasheng ZhangFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Jae-Joon JungFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Yunpeng YeFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Michelle de RooFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Koen HilgerinkFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Chi LiuFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Simon P RobinsonFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.).
Mehran M SadeghiFrom the Section of Cardiovascular Medicine and Cardiovascular Research Center (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.), Department of Diagnostic Radiology (C.L.), Yale University School of Medicine, New Haven, CT; VA Connecticut Healthcare System, West Haven (R.G., M.R., L.N., J.Z., J.-J.J., Y.Y, M.d.R., K.H., M.M.S.); and Lantheus Medical Imaging, North Billerica, MA (S.P.R.). Mehran.sadeghi@yale.edu.
VA Connecticut Healthcare System · US

Funding

Imaging protease activation in calcific aortic valve diseaseR01HL114703 · NHLBI · YALE UNIVERSITY · PI SADEGHI, MEHRAN M · 2012 to 2016
$2.0M
Macrophage elastase and its imaging in vascular inflammation and remodelingR01HL112992 · NHLBI · YALE UNIVERSITY · PI SADEGHI, MEHRAN M · 2013 to 2016
$2.0M
Molecular Imaging of Protease Activation in AneurysmI01BX001750 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI SADEGHI, MEHRAN M · 2013 to 2016
–
BLRD VA I01 BX001750NHLBI NIH HHS R01 HL112992NHLBI NIH HHS R01 HL114703
6 · The paper itself

Abstract

backgroundAbdominal aortic aneurysm (AAA) rupture risk is currently determined based on size and symptoms. This approach does not address the rupture risk associated with small aneurysms. Given the role of matrix metalloproteinases (MMPs) in AAA weakening and rupture, we investigated the potential of MMP-targeted imaging for detection of aneurysm biology and prediction of outcome in a mouse model of AAA with spontaneous rupture. METHODS AND

resultsFifteen-week-old mice (n=66) were infused with angiotensin II for 4 weeks to induce AAA. Saline-infused mice (n=16) served as control. The surviving animals underwent in vivo MMP-targeted micro-single photon emission computed tomographic/computed tomographic imaging, using RP805, a technetium-99m-labeled MMP-specific tracer, followed by ex vivo planar imaging, morphometry, and gene expression analysis. RP805 uptake in suprarenal aorta on micro-single photon emission computed tomographic images was significantly higher in animals with AAA when compared with angiotensin II-infused animals without AAA or control animals. CD68 expression and MMP activity were increased in AAA, and significant correlations were noted between RP805 uptake and CD68 expression or MMP activity but not aortic diameter. A group of angiotensin II-infused animals (n=24) were imaged at 1 week and were followed up for additional 3 weeks. RP805 uptake in suprarenal aorta at 1 week was significantly higher in mice that later developed rupture or AAA. Furthermore, tracer uptake at 1 week correlated with aortic diameter at 4 weeks.

conclusionsMMP-targeted imaging reflects vessel wall inflammation and can predict future aortic expansion or rupture in murine AAA. If confirmed in humans, this may provide a new paradigm for AAA risk stratification.

Indexed as

Aorta, AbdominalAngiotensin IIAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAortic Aneurysm, AbdominalAortic RuptureAortographyBiomarkersCD68 MoleculeDisease Models, AnimalDisease ProgressionEnzyme ActivationFeasibility StudiesMaleMatrix MetalloproteinasesAngiotensin IIAntigens, CDAntigens, Differentiation, MyelomonocyticBiomarkersCD68 MoleculeCD68 protein, mouseMatrix MetalloproteinasesRadiopharmaceuticalsaneurysminflammationmatrix metalloproteinasesmolecular imaging

Identifiers

PMID25550400
PMCPMC4284949
OpenAlexW2154568462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.